TNDM
TNDM
US8753722037
Tandem Diabetes Care, Inc.
Loading chart...

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Latest News

Related stocks

LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
AVNS
AVNS • United States
Avanos Medical, Inc.
24.99 USD
1.17B USD
CBLL
CBLL • United States
CeriBell, Inc.
23.63 USD
906.87M USD 1Y +89.1%
ENOV
ENOV • United States
Enovis Corporation
17.69 USD
1.02B USD 1Y -45.2%
ALMR
ALMR • United States
Alamar Biosciences, Inc.
25.27 USD
1.75B USD
AHCO
AHCO • United States
AdaptHealth Corp.
6.06 USD
824.49M USD 1Y -32.3%
IART
IART • United States
Integra LifeSciences Holdings C
13.44 USD
1.05B USD 1Y -9.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
69.0% p.a.
Max Drawdown (5Y)
-93.4%
Sharpe Ratio (5Y)
-0.53
Beta Factor
1.66
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 567%.
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.66 indicates above-average volatility compared to the broader market.
🔴 High valuation risk: Avg P/E of 101.3 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (73.7%) is noticeably higher than the 5Y average (69.0%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (69.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -97.1% in the extended horizon.
ende